# Lipella Pharmaceuticals Inc. (LIPO)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/LIPO/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 0 | $ -3.98M | $ -2.42B | $ 264.1K | $ 1.49M |
| 2024 | $ 182.5K | $ -5.27M | $ -4.15M | $ 47.6K | $ 1.92M |
| 2023 | $ 598.7K | $ -4.99M | $ -3.42M | $ 136.6K | $ 3.14M |
| 2022 | $ 205.7K | $ -2.90M | $ -2.05M | $ 429.5K | $ 4.68M |
| 2021 | $ 308.3K | $ -2.22M | $ -1.18M | $ 283.0K | $ 1.42M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.18 |
| Liabilities / Eq | 0.58 |
| Current Ratio | 3.24 |

## Other views

- [Metrics](https://sponda.capital/en/LIPO.md)
- [Charts](https://sponda.capital/en/LIPO/charts.md)
- [Compare](https://sponda.capital/en/LIPO/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.